Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(17%)
Results Posted
50%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_4
1
17%
Ph phase_1
1
17%
Ph not_applicable
2
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

terminated117%
active_not_recruiting117%
completed467%

Recent Activity

1 active trials
Showing 5 of 6
active_not_recruiting

ISCHEMIA-EXTEND (Extended Follow-up)

NCT04894877
completednot_applicable

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

NCT01471522
completedphase_4

ISCHEMIA-Chronic Kidney Disease Trial

NCT01985360
terminatednot_applicable

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

NCT00997828
completed

Optilene® Suture for Coronary Artery Bypass Graft Surgery

NCT02546557
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04894877

ISCHEMIA-EXTEND (Extended Follow-up)

Active Not Recruiting
NCT01471522Not Applicable

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

Completed
NCT01985360Phase 4

ISCHEMIA-Chronic Kidney Disease Trial

Completed
NCT00997828Not Applicable

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Terminated
NCT02546557

Optilene® Suture for Coronary Artery Bypass Graft Surgery

Completed
NCT01488084Phase 1

Assessing Vein Graft Properties Between Conventional & No-Touch Harvesting Technique - (PATENT SVG)

Completed

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6